Drugs / INO-A002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03831503 | Feb 2019 → Oct 2022 | — | University of Pennsylvania | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INO-A002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03831503 ↗ |
| Route | Intramuscular | “Participants will receive one or two 1 ml IM injections (in different arms) into the deltoid region at day 0 (all groups), and in addition on day 3 (in the 2 mg and 4 mg cohorts).” NCT03831503 ↗ |